Previous studies have demonstrated that treatment with Astragalus-containing CHM (SH003) reduces the levels of expression for G1 phase-related CDK (CDK2, CDK4, and CDK6) and cyclin D and induces extrinsic cell apoptosis in HeLa cervical cancer cells (Lee et al., 2017). This evidence concerns the gene CDK2 and cervical cancer.